3,5-Disubstituted-indole-7-carboxamides: The discovery of a novel series of potent, selective inhibitors of IKK-β

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

The discovery and hit-to-lead exploration of a novel series of selective IKK-β kinase inhibitors is described. The initial lead fragment 3 was identified by pharmacophore-directed virtual screening. Homology model-driven SAR exploration of the template led to potent inhibitors, such as 12, which demonstrate efficacy in cellular assays and possess encouraging developability profiles.

Knowledge Graph

Similar Paper

3,5-Disubstituted-indole-7-carboxamides: The discovery of a novel series of potent, selective inhibitors of IKK-β
Bioorganic & Medicinal Chemistry Letters 2011.0
IKKβ inhibitors identification part I: Homology model assisted structure based virtual screening
Bioorganic & Medicinal Chemistry 2009.0
Novel IKKβ inhibitors discovery based on the co-crystal structure by using binding-conformation-based and ligand-based method
European Journal of Medicinal Chemistry 2013.0
Structure-based design and biological profile of (E)-N-(4-Nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of IκB kinase-β
European Journal of Medicinal Chemistry 2011.0
Novel IKK inhibitors: β-carbolines
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 2: Improvement of in vitro activity
Bioorganic & Medicinal Chemistry Letters 2004.0
Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
European Journal of Medicinal Chemistry 2010.0
Discovery and Structure−Activity Relationship of 3-Aminopyrid-2-ones as Potent and Selective Interleukin-2 Inducible T-Cell Kinase (Itk) Inhibitors
Journal of Medicinal Chemistry 2011.0
Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-β type I receptor (ALK5) inhibitors
European Journal of Medicinal Chemistry 2009.0
Virtual Screening to Successfully Identify Novel Janus Kinase 3 Inhibitors: A Sequential Focused Screening Approach
Journal of Medicinal Chemistry 2008.0